RedShift BioAnalytics, Inc. — Form D
RedShift BioAnalytics, Inc. of Boxborough, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-22. The offering totals $10.0M, of which $6.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2018-10-22
- Form: D
- Accession: 0001349049-18-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $6.0M
- Remaining: $4.0M
- Investors: 11
- Date of first sale: 2018-09-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-324049
Issuer
- Name: RedShift BioAnalytics, Inc.
- CIK: 0001349049
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 80 Central Street, Boxborough, MA, 01719
- Phone: 781-345-7300
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Paul Tardif | Director | Windham, NH |
| Frank Smith | Director | Marlborough, MA |
| William Cadogan | Director | Boxborough, MA |
| Bryson Hollimon | Director | Boxborough, MA |
| Susan Holleran | Director | Boxborough, MA |
| Wouter Meuleman | Director | Boxborough, MA |
| Thomas O'Lenic | Director | Boxborough, MA |
| Thomas O'Lenic | Executive Officer | Boxborough, MA |
| Charles Purtell | Director | Vienna, VA |
| Mark Cafazzo | Director | Boxborough, MA |
| Amol Chaubal | Director | Boxborough, MA |
| Julien Bradley | Director | Burlington, MA |
| Julien Bradley | Executive Officer | Burlington, MA |
| Don Bossi | Director | Minneapolis, MN |
| Rob Carson | Director | Burlington, MA |
| Charles Marshall | Director | Burlington, MA |
| Charles Marshall | Executive Officer | Burlington, MA |
| Eugene Ma | Executive Officer | Burlington, MA |
| Bryson Holliman | Director | Burlington, MA |
Other filings by this issuer (9)
More